Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-Aβ, tumor necrosis factor and complement component C3 in mouse macrophages

A. Celada, Michael Klemsz, R. A. Maki

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The purpose of this study was to obtain additional information on the mechanism by which interferon-γ (IFN-γ) is able to regulate gene expression in macrophages. The expression of the genes for class II histocompatibility I-Aβ, tumor necrosis factor (TNF) and complement component C3 was assayed after treating bone marrow macrophages with IFN-γ. Each gene displayed a characteristic pattern of regulation. First, the increase in the level of RNA for each gene followed different kinetics. The level of TNF RNA increased within 15 min after IFN-γ treatment and reached a plateau after 4 h. In contrast, there was a lag of about 4 h before the level of I-Aβ RNA began to rise and plateau was not reached until 48 h after the IFN-γ treatment began. C3 gene expression followed an intermediate time course between that for TNF and I-Aβ. Second, the expression of I-Aβ was inhibited when cells were treated with both IFN-γ and cycloheximide, while the expression of TNF and C3 was not. Interestingly, the sensitivity to cycloheximide only lasted 30 min following the addition of IFN-γ, after which cycloheximide had no effect on the expression of I-Aβ. Third, lipopolysaccharide abolished the IFN-γ-induced expression of I-Aβ, but enhanced the expression of TNF. Based on these observations, we conclude that IFN-γ must activate multiple pathways to regulate gene expression in macrophages.

Original languageEnglish (US)
Pages (from-to)1103-1109
Number of pages7
JournalEuropean Journal of Immunology
Volume19
Issue number6
StatePublished - 1989
Externally publishedYes

Fingerprint

Complement C3
Histocompatibility
Interferons
Tumor Necrosis Factor-alpha
Macrophages
Gene Expression
Cycloheximide
RNA
MHC Class II Genes
Genes
Lipopolysaccharides
Bone Marrow

ASJC Scopus subject areas

  • Immunology

Cite this

@article{bdd43fb6ad1144e3bd6ed867ffc0fb80,
title = "Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-Aβ, tumor necrosis factor and complement component C3 in mouse macrophages",
abstract = "The purpose of this study was to obtain additional information on the mechanism by which interferon-γ (IFN-γ) is able to regulate gene expression in macrophages. The expression of the genes for class II histocompatibility I-Aβ, tumor necrosis factor (TNF) and complement component C3 was assayed after treating bone marrow macrophages with IFN-γ. Each gene displayed a characteristic pattern of regulation. First, the increase in the level of RNA for each gene followed different kinetics. The level of TNF RNA increased within 15 min after IFN-γ treatment and reached a plateau after 4 h. In contrast, there was a lag of about 4 h before the level of I-Aβ RNA began to rise and plateau was not reached until 48 h after the IFN-γ treatment began. C3 gene expression followed an intermediate time course between that for TNF and I-Aβ. Second, the expression of I-Aβ was inhibited when cells were treated with both IFN-γ and cycloheximide, while the expression of TNF and C3 was not. Interestingly, the sensitivity to cycloheximide only lasted 30 min following the addition of IFN-γ, after which cycloheximide had no effect on the expression of I-Aβ. Third, lipopolysaccharide abolished the IFN-γ-induced expression of I-Aβ, but enhanced the expression of TNF. Based on these observations, we conclude that IFN-γ must activate multiple pathways to regulate gene expression in macrophages.",
author = "A. Celada and Michael Klemsz and Maki, {R. A.}",
year = "1989",
language = "English (US)",
volume = "19",
pages = "1103--1109",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "6",

}

TY - JOUR

T1 - Interferon-γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-Aβ, tumor necrosis factor and complement component C3 in mouse macrophages

AU - Celada, A.

AU - Klemsz, Michael

AU - Maki, R. A.

PY - 1989

Y1 - 1989

N2 - The purpose of this study was to obtain additional information on the mechanism by which interferon-γ (IFN-γ) is able to regulate gene expression in macrophages. The expression of the genes for class II histocompatibility I-Aβ, tumor necrosis factor (TNF) and complement component C3 was assayed after treating bone marrow macrophages with IFN-γ. Each gene displayed a characteristic pattern of regulation. First, the increase in the level of RNA for each gene followed different kinetics. The level of TNF RNA increased within 15 min after IFN-γ treatment and reached a plateau after 4 h. In contrast, there was a lag of about 4 h before the level of I-Aβ RNA began to rise and plateau was not reached until 48 h after the IFN-γ treatment began. C3 gene expression followed an intermediate time course between that for TNF and I-Aβ. Second, the expression of I-Aβ was inhibited when cells were treated with both IFN-γ and cycloheximide, while the expression of TNF and C3 was not. Interestingly, the sensitivity to cycloheximide only lasted 30 min following the addition of IFN-γ, after which cycloheximide had no effect on the expression of I-Aβ. Third, lipopolysaccharide abolished the IFN-γ-induced expression of I-Aβ, but enhanced the expression of TNF. Based on these observations, we conclude that IFN-γ must activate multiple pathways to regulate gene expression in macrophages.

AB - The purpose of this study was to obtain additional information on the mechanism by which interferon-γ (IFN-γ) is able to regulate gene expression in macrophages. The expression of the genes for class II histocompatibility I-Aβ, tumor necrosis factor (TNF) and complement component C3 was assayed after treating bone marrow macrophages with IFN-γ. Each gene displayed a characteristic pattern of regulation. First, the increase in the level of RNA for each gene followed different kinetics. The level of TNF RNA increased within 15 min after IFN-γ treatment and reached a plateau after 4 h. In contrast, there was a lag of about 4 h before the level of I-Aβ RNA began to rise and plateau was not reached until 48 h after the IFN-γ treatment began. C3 gene expression followed an intermediate time course between that for TNF and I-Aβ. Second, the expression of I-Aβ was inhibited when cells were treated with both IFN-γ and cycloheximide, while the expression of TNF and C3 was not. Interestingly, the sensitivity to cycloheximide only lasted 30 min following the addition of IFN-γ, after which cycloheximide had no effect on the expression of I-Aβ. Third, lipopolysaccharide abolished the IFN-γ-induced expression of I-Aβ, but enhanced the expression of TNF. Based on these observations, we conclude that IFN-γ must activate multiple pathways to regulate gene expression in macrophages.

UR - http://www.scopus.com/inward/record.url?scp=0024390901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024390901&partnerID=8YFLogxK

M3 - Article

C2 - 2502420

AN - SCOPUS:0024390901

VL - 19

SP - 1103

EP - 1109

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 6

ER -